Geoffrey C. Dunbar

2010

In 2010, Geoffrey C. Dunbar earned a total compensation of $1.1M as Senior Vice President, Clinical Development and Regulatory Affairs and Chief Medical Officer at Catalyst Biosciences, a 88% increase compared to previous year.

Compensation breakdown

Bonus$11,760
Non-Equity Incentive Plan$57,836
Option Awards$667,580
Salary$321,312
Other$9,800
Total$1,068,288

Dunbar received $667.6K in option awards, accounting for 62% of the total pay in 2010.

Dunbar also received $11.8K in bonus, $57.8K in non-equity incentive plan, $321.3K in salary and $9.8K in other compensation.

Rankings

In 2010, Geoffrey C. Dunbar's compensation ranked 5,052nd out of 10,439 executives tracked by ExecPay. In other words, Dunbar earned more than 51.6% of executives.

ClassificationRankingPercentile
All
5,052
out of 10,439
52nd
Division
Manufacturing
1,818
out of 3,838
53rd
Major group
Chemicals And Allied Products
374
out of 921
59th
Industry group
Drugs
221
out of 680
68th
Industry
Pharmaceutical Preparations
171
out of 481
64th
Source: SEC filing on April 21, 2011.

Dunbar's colleagues

We found four more compensation records of executives who worked with Geoffrey C. Dunbar at Catalyst Biosciences in 2010.

2010

J deBethizy

Catalyst Biosciences

Chief Executive Officer

2010

Jeffrey Brennan

Catalyst Biosciences

Former Senior Vice President, Business and Commercial Development and Chief Business Officer

2010

Alan Musso

Catalyst Biosciences

Chief Financial Officer

2010

Peter Zorn

Catalyst Biosciences

General Counsel

In-depth

You may also like